Search for content, post, videos

AstraZeneca collaborates with Accent Therapeutics

Jose Baselga
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer. This collaboration focuses on targeting RMPs, proteins that control many aspects of RNA biology and represe
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.